Table 1 Description of SNPs included in the study
From: Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population
Gene | Polymorphism | Locus |
|---|---|---|
Adrenergic beta-2-receptor (ADRB2) | rs1042713 | 5q31–q32 |
Advanced glycosylation end product-specific receptor (AGER) | rs2070600 | 6p21.3 |
Advanced glycosylation end product-specific receptor (AGER) | rs1800624 | 6p21.3 |
Angiotensin II receptor, type 1 (AGTR1) | rs5186 | 3q24 |
Angiotensin II receptor, type 1 (AGTR1) | rs5182 | 3q24 |
Butyrylcholinesterase (BCHE) | rs1803274 | 3q26.1–q26.2 |
Chemokine (C–C motif) ligand 11 (CCL11) | rs4795895 | 17q21.1–q21.2 |
Cluster of differentiation 14 (CD14) | rs2569190 | 5q31.1 |
Cyclin-dependent kinase inhibitor 1B (p27, Kip1, CDKN1B) | rs34330 | 12p13.1–p12 |
Collagen, type III, alpha 1 (Col3A1) | rs1800255 | 2q31 |
Colony stimulating factor 2 (CSF2) | rs25882 | 5q31.1 |
Chemokine (C-X3-C motif) receptor 1 (CX3CR1) | rs3732379 | 3p21.3 |
Cytochrome b-245, alpha polypeptide (CYBA) | rs4673 | 16q24 |
Cytochrome P450, family2, subfamily C, polypeptide 19 (CYP2C19) | rs12248560 | 10q24 |
Fibrinogen beta chain (FGB) | rs1800790 | 4q28 |
Fibrinogen beta chain (FGB) | rs1044291 | 4q28 |
Coagulation factor V (F5) | rs6025 | 1q23 |
Glutathione peroxidase 1 (GPX1) | rs8179164 | 3p21.3 |
Integrin, beta 2 (ITGB2) | rs235326 | 21q22.3 |
Lipoprotein lipase (LPL) | rs328 | 8p22 |
Matrix metallopeptidase 12 (MMP12) | rs12808148 | 11q22.3 |
Matrix metallopeptidase 12 (MMP12) | rs17099726 | 20q11.2–q13.1 |
Matrix metallopeptidase 12 (MMP12) | rs2276109 | 20q11.2–q13.1 |
Methylenetetrahydrofolate reductase (NAD(P)H) MTHFR) | rs1801133 | 1p36.3 |
Nitric oxide synthase 3 (NOS3) | rs2070744 | 7q36 |
Nitric oxide synthase 3 (NOS3) | rs1799983 | 7q36 |
K(lysine) acetyltransferase2B (KAT2B, PCAF) | rs2948080 | 3p24 |
K(lysine) acetyltransferase2B (KAT2B, PCAF) | rs6776870 | 3p24 |
K(lysine) acetyltransferase2B (KAT2B, PCAF) | rs2929404 | 3p24 |
K(lysine) acetyltransferase2B (KAT2B, PCAF) | rs17796904 | 3p24 |
Peroxisome proliferator-activated receptor gamma (PPARG) | rs3856806 | 3p25 |
C-ros oncogene1, receptor tyrosine kinase (ROS1) | rs529038 | 6q22 |
Thrombomodulin (THBD) | rs1042579 | 20p11.2 |
Thrombospondin 4 (THBS4) | rs1866389 | 5q13 |
Thrombopoietin (THPO) | rs6141 | 3q27 |
Tumor protein p53 (TP53) | rs1042522 | 17p13.1 |
Transferrin (TF) | rs1799899 | 3p |
Uncoupling protein 3 (UCP3) | rs1800849 | 11q13.4 |
Vitamin D receptor (VDR) | rs11568820 | 12q13.11 |
Vitamin D receptor (VDR) | rs11574027 | 12q13.11 |
Vitamin D receptor (VDR) | rs11574077 | 12q13.11 |
Tumor necrosis factor α (TNFα) | rs1800629 | 6p21.3 |
Tumor necrosis factor α (TNFα) | rs361525 | 6p21.3 |
Interleukin 1 receptor antagonist (IL1RN) | rs419598 | 2q14.2 |
Interleukin 1α (IL1A) | rs1800587 | 2q12–q21 |
Interleukin 1 β (IL1B) | rs1143627 | 2q13–q21 |
Interleukin 4 (IL4) | rs2243250 | 5q23–31 |
Interleukin 6 (IL6) | rs1800796 | 7p21 |
Interleukin 8 (IL8) | rs 4073 | 4q12–q13 |
Interleukin 10 (IL10) | rs1800871 | 1q31–q32 |
Interleukin 10 (IL10) | rs1800872 | 1q31–q32 |
Interleukin 10 (IL10) | rs1800896 | 1q31–q32 |
Interleukin 10 (IL10) | rs3024498 | 1q31–q32 |